← Back to Search

Unknown

CBP-4888 for Healthy Volunteers

Q: Does this experiment extend to geriatric patients?

As per the regulations of this medical trial, individuals must be over 18 and under 50 to qualify for enrollment.

Q: What is the limit of participants in this research endeavor?

Correct. According to the clinicaltrials.gov records, this medical trial is actively recruiting patients since its initial posting on May 1st 2023 and latest update from May 19th 2023. The research team needs 15 people across one site for participation.

Q: Is this research currently open to participants?

The clinical trial is open and accepting applications as of 5/19/2023, with the original post being on 5/1/2023. This information can be found at clinicaltrials.gov.

Q: Am I eligible to get involved in this clinical experimentation?

To be considered, applicants should have a clean bill of health and must fall within the age parameters of 18 to 50. This study is recruiting approximately 15 participants in total.

Phase < 1

Recruiting

Research Sponsored by Comanche Biopharma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days

Awards & highlights

Study Summary

This trial evaluates the safety and effectiveness of a new drug, and tests how it's tolerated and how it works in the body.

Who is the study for?

This trial is for healthy, non-pregnant women with a BMI between 18.5 and 35.0 kg/m2. Participants should have no significant health issues based on lab tests, medical history, vital signs, ECGs, or physical exams as determined by the study's doctor.Check my eligibility

What is being tested?

The study is testing CBP-4888 in its first human trial phase to see how safe it is and how the body processes it. It's a randomized test where some get CBP-4888 and others get a placebo without knowing which one they receive.See study design

What are the potential side effects?

Since this is an initial test of CBP-4888 in humans, potential side effects are not yet known but will be closely monitored for anything unusual like allergic reactions or symptoms affecting any part of the body.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adverse Events

Erythema at Site of Injection

Pain at Site of Injection

+2 more

Secondary outcome measures

AUC of CBP-4888

Cmax of CBP-4888

Tmax of CBP-4888

Other outcome measures

Pharmacodynamics

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: CBP-4888Experimental Treatment1 Intervention

CBP-4888 administered once as a subcutaneous dose.

Group II: PlaceboPlacebo Group1 Intervention

Normal Saline administered once as a subcutaneous dose.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Comanche BiopharmaLead Sponsor

Allison August, MDStudy DirectorChief Medical Officer

Media Library

CBP-4888 (Unknown) Clinical Trial Eligibility Overview. Trial Name: NCT05881993 — Phase < 1

Healthy Volunteer Study Research Study Groups: CBP-4888, Placebo

Healthy Volunteer Study Clinical Trial 2023: CBP-4888 Highlights & Side Effects. Trial Name: NCT05881993 — Phase < 1

CBP-4888 (Unknown) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05881993 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment extend to geriatric patients?

"As per the regulations of this medical trial, individuals must be over 18 and under 50 to qualify for enrollment."

Answered by AI

What is the limit of participants in this research endeavor?

"Correct. According to the clinicaltrials.gov records, this medical trial is actively recruiting patients since its initial posting on May 1st 2023 and latest update from May 19th 2023. The research team needs 15 people across one site for participation."

Answered by AI

Is this research currently open to participants?

"The clinical trial is open and accepting applications as of 5/19/2023, with the original post being on 5/1/2023. This information can be found at clinicaltrials.gov."

Answered by AI

Am I eligible to get involved in this clinical experimentation?

"To be considered, applicants should have a clean bill of health and must fall within the age parameters of 18 to 50. This study is recruiting approximately 15 participants in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects

2023. "Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05881993.